FFCP PHASE2:Hg19::chr7:92463234..92463293,-
From FANTOM5_SSTAR
Jump to: navigation, search
| Short description: | p2@CDK6 |
|---|---|
| Species: | Human (Homo sapiens) |
| DPI dataset: | Robust |
| TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
| DHS support(Yes/No): | Yes |
| Description: | CAGE_peak_2_at_CDK6_5end |
| Coexpression cluster: | C2905_granulocyte_lymphoma_acute_Hodgkin_CD34_CD133_neuroblastoma |
| Association with transcript: | -3bp_to_ENST00000265734, NM_001259, uc011khw.1_5end |
| EntrezGene: | CDK6 |
| HGNC: | 1777 |
| UniProt: | Q00534A4D1G0 |
| Genome view: | ZENBU |
View on UCSC genome browser
Mouse over to see Genome browser image, Click image to go to Genome browser
CAGE Expression
| Sample | p2@CDK6 |
|---|
0
50
100
150
200
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
| Ontology term | p-value | n |
|---|---|---|
| organ system subdivision | 1.74e-12 | 223 |
| nervous system | 1.11e-11 | 89 |
| central nervous system | 1.13e-11 | 81 |
| brain | 4.67e-11 | 68 |
| future brain | 4.67e-11 | 68 |
| neural tube | 2.79e-10 | 56 |
| neural rod | 2.79e-10 | 56 |
| future spinal cord | 2.79e-10 | 56 |
| neural keel | 2.79e-10 | 56 |
| regional part of nervous system | 1.05e-09 | 53 |
Showing 1 to 10 of 23 entries
| Ontology term | p-value | n |
|---|---|---|
| cancer | 2.15e-13 | 235 |
| hematologic cancer | 1.52e-12 | 51 |
| immune system cancer | 1.52e-12 | 51 |
| disease of cellular proliferation | 1.72e-12 | 239 |
| leukemia | 4.38e-09 | 39 |
| organ system cancer | 1.25e-08 | 137 |
Showing 1 to 6 of 6 entries
